查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1777478

全球早產及胎膜早破檢測市場

Preterm Birth and PROM Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 293 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球早產和胎膜早破檢測市場規模將達 23 億美元

全球早產和胎膜早破（PROM）檢測市場規模預計在2024年為15億美元，到2030年預計將達到23億美元，在2024-2030年的分析期內，複合年成長率為7.4%。骨盆腔檢查是本報告分析的細分市場之一，預計其複合年成長率為8.8%，到分析期結束時市場規模將達到7.017億美元。胎兒纖連蛋白檢測細分市場在分析期間的複合年成長率預計為8.1%。

美國市場規模估計為 4.05 億美元，中國市場預計複合年成長率為 11.7%

美國早產和胎膜早破（PROM）檢測市場規模預計在2024年達到4.05億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到4.859億美元，在2024-2030年的分析期間內，複合年成長率為11.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.6%和7.2%。在歐洲，預計德國市場的複合年成長率為4.9%。

全球早產和胎膜早破檢測市場—主要趨勢和促進因素摘要

早產和胎膜早破檢測如何改善產婦和新生兒護理？

早產和胎膜早破 (PROM) 檢測已成為產婦保健的重要工具，可實現對影響胎兒發育和新生兒存活的併發症的早期診斷和風險評估。早產是指妊娠 37 週前分娩，是全世界新生兒死亡和發病的主要原因之一。胎膜早破（分娩開始前羊膜囊自然破裂）會顯著增加感染疾病、早產和新生兒併發症的風險。先進的診斷方法，如基於生物標記的檢測、胎兒纖連蛋白(fFN) 檢測和照護現場(POC) 解決方案，正在改變臨床醫生預測和管理早產的方式。快速診斷工具在產科護理中的整合已經導致了決策的改進、及時干預和更好的懷孕結果。隨著醫療保健系統將重點放在降低早產率和提高新生兒存活率上，早產和胎膜早破檢測已成為產科醫院、診所和高風險妊娠監測計畫的重要組成部分。

影響早產和胎膜早破檢測採用的挑戰有哪些？

儘管早產和胎膜早破檢測至關重要，但其推廣應用仍面臨許多挑戰，影響市場擴張和可及性。其中一個主要問題是先進診斷檢測的成本，這使得它們在資源匱乏、孕產婦保健基礎設施有限的地區難以普及。此外，檢測準確性參差不齊和假陽性率高低可能導致不必要的住院、類固醇和緊急藥物的使用，以及醫療成本的增加。由於早產風險管理通訊協定因醫療體係而異，缺乏統一實施這些檢測的標準化指南，進一步加劇了臨床決策的複雜性。另一個挑戰是產婦對早產和胎膜早破檢測的認知度有限，導致診斷和介入延遲。此外，監管核准和嚴格的臨床檢驗要求也阻礙了創新檢測解決方案的商業化，並降低了市場應用率。應對這些挑戰需要持續的研究、經濟高效的檢測開發以及有針對性的宣傳活動，以加強對醫護人員和患者的教育。

診斷創新如何改變早產和胎膜早破檢測

母胎診斷技術的進步徹底改變了早產和胎膜早破檢測，提高了準確性、效率和可及性。基於胎盤α-微球蛋白-1（PAMG-1）和胰島素樣生長因子結合蛋白-1（IGFBP-1）等非侵入性生物標記檢測的開發，提高了高靈敏度和特異性檢測胎膜早破的能力。人工智慧預測分析和機器學習演算法也被整合到孕產婦健康監測中，使臨床醫生能夠使用患者病歷、生理數據和即時生物標記追蹤來評估早產風險。可攜式和即時檢測設備使偏遠和低度開發地區更容易獲得診斷，從而能夠對高風險妊娠進行早期療育。遠端醫療和數位健康平台的興起進一步提高了早產診斷的可用性，為孕婦提供了即時諮詢和個人化風險評估的機會。隨著精準醫療在產科護理中變得越來越普遍，早產和胎膜早破檢測將變得更加複雜，從而能夠制定個人化的治療策略並改善周產期結果。

是什麼推動了早產和胎膜早破檢測市場的成長？

早產和胎膜早破檢測市場的成長受到多種因素的推動，包括全球早產率的上升、孕產婦保健診斷技術的進步以及就地檢驗解決方案的日益普及。人們越來越重視降低新生兒死亡率和發病率，這加速了對早期和準確的早產檢測方法的需求，從而導致對創新診斷技術的投資增加。隨著醫療保健提供者優先考慮早期篩檢和干涉策略，母胎醫學計畫和高風險妊娠診所的擴展進一步推動了市場的成長。此外，政府為改善孕產婦健康所採取的措施和提供的資金正在推動公共醫療系統採用先進的檢測解決方案。醫療保健的快速數位化和人工智慧在妊娠監測中的整合也使得更準確、更容易取得的風險評估工具成為可能，從而創造了新的市場機會。隨著對個人化孕產婦保健的需求持續成長，早產和胎膜早破檢測市場預計將經歷持續成長，並透過早期診斷和有針對性的干涉措施改變孕產婦保健。

部分

檢查類型（骨盆檢查、超音波、生化標記、子宮監測檢查、尼替丁檢查、胎兒子宮內試驗、合併試驗、PAMG-1免疫檢測檢查、IGFBP檢查、胎兒纖連蛋白檢查、其他檢查類型）、目的（PROM、早產、絨毛膜羊膜炎）

受訪公司範例

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP32688

Global Preterm Birth and PROM Testing Market to Reach US$2.3 Billion by 2030

The global market for Preterm Birth and PROM Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Pelvic Exam Test, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$701.7 Million by the end of the analysis period. Growth in the Fetal Fibronectin Test segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$405.0 Million While China is Forecast to Grow at 11.7% CAGR

The Preterm Birth and PROM Testing market in the U.S. is estimated at US$405.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$485.9 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Preterm Birth and PROM Testing Market - Key Trends & Drivers Summarized

How Is Preterm Birth and PROM Testing Improving Maternal and Neonatal Care?

Preterm birth and premature rupture of membranes (PROM) testing have become essential tools in maternal healthcare, enabling early diagnosis and risk assessment for complications that can impact fetal development and neonatal survival. Preterm birth, defined as delivery before 37 weeks of gestation, is one of the leading causes of neonatal mortality and morbidity worldwide. Premature rupture of membranes, the spontaneous breaking of the amniotic sac before labor begins, significantly increases the risk of infection, preterm delivery, and neonatal complications. Advanced diagnostic methods, including biomarker-based assays, fetal fibronectin (fFN) tests, and point-of-care (POC) testing solutions, are transforming the way clinicians predict and manage preterm labor. The integration of rapid diagnostic tools in obstetric care has led to improved decision-making, timely interventions, and better pregnancy outcomes. As healthcare systems focus on reducing preterm birth rates and improving neonatal survival, preterm birth and PROM testing are becoming indispensable in maternity hospitals, clinics, and high-risk pregnancy monitoring programs.

What Challenges Are Affecting the Adoption of Preterm Birth and PROM Testing?

Despite its importance, the adoption of preterm birth and PROM testing faces several challenges that impact market expansion and accessibility. One of the primary concerns is the cost associated with advanced diagnostic tests, making them less accessible in low-resource settings where maternal healthcare infrastructure is limited. Additionally, the variability in test accuracy and false-positive rates can lead to unnecessary hospitalizations, administration of steroids or tocolytics, and increased healthcare costs. The lack of standardized guidelines for the universal implementation of these tests further complicates clinical decision-making, as different healthcare systems adopt varying protocols for managing preterm labor risk. Another challenge is the limited awareness among expectant mothers regarding the availability of preterm birth and PROM tests, leading to delayed diagnosis and intervention. Moreover, regulatory approvals and stringent clinical validation requirements slow down the commercialization of innovative testing solutions, delaying widespread market adoption. Addressing these challenges requires continuous research, cost-effective test development, and targeted awareness campaigns to enhance healthcare provider and patient education.

How Are Innovations in Diagnostic Technologies Transforming Preterm Birth and PROM Testing?

Technological advancements in maternal-fetal diagnostics are revolutionizing preterm birth and PROM testing, improving accuracy, efficiency, and accessibility. The development of non-invasive and biomarker-based assays, such as placental alpha-microglobulin-1 (PAMG-1) and insulin-like growth factor-binding protein-1 (IGFBP-1) tests, has enhanced the ability to detect PROM with high sensitivity and specificity. AI-powered predictive analytics and machine learning algorithms are also being integrated into maternal health monitoring, allowing clinicians to assess preterm birth risk using patient history, physiological data, and real-time biomarker tracking. Portable and point-of-care testing devices are making diagnostics more accessible in remote and underdeveloped regions, enabling early intervention in at-risk pregnancies. The rise of telemedicine and digital health platforms is further enhancing the reach of preterm birth diagnostics, allowing pregnant women to access real-time consultations and personalized risk assessments. As precision medicine gains traction in obstetric care, preterm birth and PROM testing are expected to become more sophisticated, enabling tailored treatment strategies and improved perinatal outcomes.

What Is Driving the Growth of the Preterm Birth and PROM Testing Market?

The growth in the preterm birth and PROM testing market is driven by several factors, including increasing global preterm birth rates, advancements in maternal healthcare diagnostics, and the rising adoption of point-of-care testing solutions. The growing focus on reducing neonatal mortality and morbidity has accelerated the demand for early and accurate preterm birth detection methods, leading to increased investment in innovative diagnostic technologies. The expansion of maternal-fetal medicine programs and high-risk pregnancy clinics has further fueled market growth, as healthcare providers prioritize early screening and intervention strategies. Additionally, government initiatives and funding for maternal health improvement are promoting the adoption of advanced testing solutions in public healthcare systems. The rapid digitalization of healthcare and the integration of AI in pregnancy monitoring are also creating new market opportunities, enabling more precise and accessible risk assessment tools. As demand for personalized maternal healthcare continues to rise, the preterm birth and PROM testing market is expected to experience sustained growth, transforming prenatal care through early diagnosis and targeted interventions.

SCOPE OF STUDY:

The report analyzes the Preterm Birth and PROM Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Pelvic Exam Test, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test, IGFBP Test, Fetal Fibronectin Test, Other Test Types); Application (PROM Application, Preterm Labor Application, Chorioamnionitis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preterm Birth and PROM Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Preterm Births Throws the Spotlight on Early and Accurate Diagnostic Solutions
    • Growing Clinical Awareness Around Premature Rupture of Membranes (PROM) Drives Adoption of Specialized Testing Tools
    • Advancements in Biomarker-Based Diagnostic Platforms Spur Innovation in Rapid and Non-Invasive PROM Detection
    • Increased Emphasis on Risk Stratification and Preventive Obstetric Care Strengthens Business Case for Early PROM Screening
    • Expansion of Point-of-Care Testing Technologies Propels Growth in Decentralized and Immediate PROM Diagnosis
    • Rising Maternal Age and Associated Pregnancy Complications Drive Demand for Predictive Preterm Birth Testing
    • Integration of Molecular Diagnostic Techniques Enhances Sensitivity and Specificity of PROM and Preterm Risk Assessments
    • Growth in Hospital-Acquired Infection Control Programs Spurs Interest in Minimally Invasive and Accurate Testing Devices
    • Development of Amniotic Fluid-Specific Detection Reagents Generates Demand for Targeted PROM Identification Tools
    • Expansion of Neonatal Intensive Care Units (NICUs) Strengthens Investment in Prenatal Risk Management Solutions
    • Emergence of Multiplex Testing Panels Accelerates Adoption of Combined PROM and Preterm Birth Diagnostic Kits
    • Regulatory Endorsements and Clinical Guidelines Drive Standardization of PROM and Preterm Testing Protocols
    • Rising Penetration of Digital Health and Remote Monitoring Platforms Spurs Innovation in At-Home PROM Test Accessibility
    • Increased Collaboration Between Diagnostic Companies and Obstetric Research Institutes Propels Evidence-Based Product Development
    • Growing Health Infrastructure in Emerging Markets Expands Access to Low-Cost, High-Efficacy PROM Testing Solutions
    • Surge in Demand for Rapid Diagnostics in Emergency Obstetric Settings Drives Point-of-Care Market Momentum
    • Heightened Focus on Reducing Neonatal Morbidity and Mortality Strengthens Value Proposition of Early PROM Detection
    • Government Funding and Public Health Campaigns Targeting Maternal Health Accelerate PROM Testing Program Implementation
    • Adoption of AI-Enabled Diagnostic Algorithms Enhances Interpretation Accuracy and Decision Support in High-Risk Pregnancies
    • Rising Consumer Awareness of Maternal-Fetal Health Drives Uptake of PROM and Preterm Screening in Private Clinics
    • Increased Commercialization of Disposable Diagnostic Devices Supports Infection Control and Compliance in Hospital Settings
    • Challenges in Reimbursement for Newer PROM Testing Technologies Spur Innovation in Cost-Effective Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preterm Birth and PROM Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pelvic Exam Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Fetal Fibronectin Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ultrasound Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochemical Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Uterine Monitoring Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nitazine Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ferning Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pooling Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for PAMG-1 Immunoassay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for IGFBP Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for PROM Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Preterm Labor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Chorioamnionitis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CHINA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • INDIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030

IV. COMPETITION